Company News

  • Snibe become the 1st in China who received FDA Cleared on CLIA product

    14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
    Issue date:2017-10-27
  • Snibe participated in the Medlab Asia Pacific 2019 as a Diamond Sponsor, Singapore

    MEDLAB Asia Pacific 2019 is held in Singapore from March 26th to 28th. This is a trade show where several main solutions and products about Medical, Oncology, Healthcare Industry, Cancer, Laboratory, Healthcare System, Clinical Chemistry, Molecular Diagnostics and Laboratory Medicine tend to put on.
    Issue date:2019-03-28
  • Snibe Showcases The World's Fastest CLIA System at MEDLAB 2019

    From Feb. 4th to 7th, Snibe brings the latest innovation MAGLUMI X8 to Medlab Middle East with booth No. Z5C20 in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 22,000 unique visitors, and housing 500 exhibitors dedicated to sharing the most recent technology available in the IVD, and medical laboratory market.
    Issue date:2019-02-06

New Product

More >>

About Us

To Be Global IVD Pioneer

Focus On Chemiluminescence Immunoassay For 24years

143Countries

10000Units

More
pk10骗局全过程揭秘 抢庄牌九技巧 360时时走势图 六肖赔多少 黑龙江时时网上购... 玩大小单双怎么才能赢 pk10破解器 手机版 齐齐哈尔麻将手机版 七乐彩几个号算中奖 二八杠棋牌游戏中心 开一个体彩店要多少钱 pt游戏交易平台 2019女篮亚洲杯直播 重庆福彩欢乐生肖玩法 控制手机 时时彩官方网